Brain researcher Hiroshi Kawabe has discovered the workings of a process that had been completely overlooked until now, and that allows nerve cells in the brain to grow and form complex networks. The study, which has now been published in the journal Neuron, shows that an enzyme which usually controls the destruction of protein components has an unexpected function in nerve cells: it controls the structure of the cytoskeleton and thus ensures that nerve cells can form the tree-like extensions that are necessary for signal transmission in the brain. (Neuron, February 11, 2010)
In the brain of mice, which cannot produce Nedd4-1, the extensions of nerve cells are shorter and of much simpler construction (example top) than in the brain of normal mice (example bottom). Image: Hiroshi Kawabe
In order to be able to receive signals from other cells, nerve cells form complex extensions called dendrites (from the Greek ‘dendron’ meaning tree). The growth of dendrites in the human brain takes place mainly during late embryonic and infantile brain development. During this phase, dendrites, with a total length of many hundred kilometres, grow from the 100 billion nerve cells in our brain. The result is a highly-complex network of nerve cells that controls all bodily functions - from breathing to complicated learning processes.
In order that this incredible growth phase of brain development does not lead to chaos, the growth of the dendrites must be accurately controlled. In fact, a large number of signal processes control the direction and the speed of dendrite growth by influencing the structure of the cytoskeleton, which is inside the growing dendrite and responsible for its shape and extension.
The Göttingen-based brain researcher Hiroshi Kawabe has now discovered exactly how the growth of the cytoskeleton is controlled during the dendrite development. Using specially bred genetically engineered mice, the Japanese guest scientist, who conducts research at the Max Planck Institute for Experimental Medicine, discovered that the Nedd4-1 enzyme is essential for regular dendrite growth. Nedd4-1 is an enzyme that usually controls the degradation of protein components in cells by combining them with another protein called ubiquitin. The cell identifies these ubiquitinated molecules as "waste" and degrades them. In some cases, however, the ubiquitination does not lead to the degradation of the marked protein but changes its function instead.
Nedd4-1 prevents degradation of the cytoskeleton
Hiroshi Kawabe has now shown that the Nedd4-1 enzyme ubiquitinates a signal protein called Rap2, and thus prevents it causing the dismemberment of the cytoskeleton and the collapse of the dendrites. "As long as Nedd4-1 is active, the nerve cell dendrites can grow normally," reports Kawabe. "In its absence, the dendrite growth comes to a standstill and previously formed dendrites collapse, with dramatic consequences for the function of nerve cell networks in the brain." There are, however, probably a number of parallel operating signal paths which control the dendrite growth. This explains why nerve cells can also form dendrites without Nedd4-1 - albeit significantly fewer in number and shorter. The Nedd4/Rap2/TNIK mechanism would then be only one of several that can partially compensate each other.
Kawabe's discovery provides important new insight into the mechanisms which control the development of the brain. "What is surprising is that no-one has investigated this before," says the Japanese biochemist. Scientists have long been aware that Nedd4-1 is one of the most prevalent ubiquitination enzymes in nerve cells and is produced with great frequency in the developmental phase when nerve cells grow and form their dendrites. As Kawabe points out, the function of Nedd4-1 has already been investigated in dozens of studies. "But very little work has been carried out on its role in nerve cell development, which would have been the obvious thing to do."
Original work:Kawabe, H., Neeb, A., Dimova, K., Young, S.M.Jr. Takeda, M., Katsurabayashi, S., Mitkovski, M., Malakhova, O.A., Zhang, D.-E., Umikawa, M., Kariya, K., Goebbels, S., Nave, K.-A., Rosenmund, C., Jahn, O., Rhee, J.-S. and Brose, N.
Neuron 65, 358-372 (2010)
Contact:Dr. Hiroshi Kawabe
Barbara Abrell | EurekAlert!
Seeking balanced networks: how neurons adjust their proteins during homeostatic scaling.
24.10.2016 | Max-Planck-Institut für Hirnforschung
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences